
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing innovative medical devices designed to improve the quality of life for patients with aortic stenosis. Our lead product, the DurAVR® transcatheter heart valve ("THV") system, repre... Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing innovative medical devices designed to improve the quality of life for patients with aortic stenosis. Our lead product, the DurAVR® transcatheter heart valve ("THV") system, represents a unique product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Our DurAVR® THV System consists of a single-piece, biomimetic valve made with our proprietary ADAPT® tissue-enhancing technology and depoloyed with our ComASUR® balloon-expahndable delivery system. ADAPT® is our proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.27 | -23.8273921201 | 5.33 | 5.74 | 3.61 | 245062 | 4.44762495 | CS |
4 | 0.27 | 7.12401055409 | 3.79 | 5.74 | 3.11 | 199124 | 4.5562797 | CS |
12 | -0.98 | -19.4444444444 | 5.04 | 5.8 | 2.34 | 228772 | 4.00028968 | CS |
26 | -1.56 | -27.7580071174 | 5.62 | 8.79 | 2.34 | 196266 | 4.967663 | CS |
52 | -1.94 | -32.3333333333 | 6 | 8.79 | 2.34 | 206917 | 5.0134266 | CS |
156 | -1.94 | -32.3333333333 | 6 | 8.79 | 2.34 | 206917 | 5.0134266 | CS |
260 | -1.94 | -32.3333333333 | 6 | 8.79 | 2.34 | 206917 | 5.0134266 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.